Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Other Working Capital Changes (2019 - 2025)

IDEAYA Biosciences' Other Working Capital Changes history spans 7 years, with the latest figure at $279000.0 for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 83.77% year-over-year to $279000.0; the TTM value through Dec 2025 reached $2.6 million, down 58.48%, while the annual FY2025 figure was $2.6 million, 58.48% down from the prior year.
  • Other Working Capital Changes for Q4 2025 was $279000.0 at IDEAYA Biosciences, up from -$192000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $9.5 million in Q3 2023 and bottomed at -$45.2 million in Q4 2022.
  • The 5-year median for Other Working Capital Changes is $43500.0 (2025), against an average of -$2.1 million.
  • The largest annual shift saw Other Working Capital Changes crashed 2234.64% in 2022 before it soared 2315.78% in 2023.
  • A 5-year view of Other Working Capital Changes shows it stood at -$1.9 million in 2021, then plummeted by 2234.64% to -$45.2 million in 2022, then soared by 98.92% to -$487000.0 in 2023, then surged by 452.98% to $1.7 million in 2024, then crashed by 83.77% to $279000.0 in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Other Working Capital Changes are $279000.0 (Q4 2025), -$192000.0 (Q3 2025), and $500000.0 (Q2 2025).